Correlation Between Oncolytics Biotech and Tff Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Oncolytics Biotech and Tff Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncolytics Biotech and Tff Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncolytics Biotech and Tff Pharmaceuticals, you can compare the effects of market volatilities on Oncolytics Biotech and Tff Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncolytics Biotech with a short position of Tff Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncolytics Biotech and Tff Pharmaceuticals.

Diversification Opportunities for Oncolytics Biotech and Tff Pharmaceuticals

0.29
  Correlation Coefficient

Modest diversification

The 3 months correlation between Oncolytics and Tff is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Oncolytics Biotech and Tff Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tff Pharmaceuticals and Oncolytics Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncolytics Biotech are associated (or correlated) with Tff Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tff Pharmaceuticals has no effect on the direction of Oncolytics Biotech i.e., Oncolytics Biotech and Tff Pharmaceuticals go up and down completely randomly.

Pair Corralation between Oncolytics Biotech and Tff Pharmaceuticals

Given the investment horizon of 90 days Oncolytics Biotech is expected to generate 0.48 times more return on investment than Tff Pharmaceuticals. However, Oncolytics Biotech is 2.1 times less risky than Tff Pharmaceuticals. It trades about -0.02 of its potential returns per unit of risk. Tff Pharmaceuticals is currently generating about -0.09 per unit of risk. If you would invest  140.00  in Oncolytics Biotech on September 3, 2024 and sell it today you would lose (49.00) from holding Oncolytics Biotech or give up 35.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Oncolytics Biotech  vs.  Tff Pharmaceuticals

 Performance 
       Timeline  
Oncolytics Biotech 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Oncolytics Biotech are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong fundamental indicators, Oncolytics Biotech is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.
Tff Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tff Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unsteady performance in the last few months, the Stock's technical and fundamental indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Oncolytics Biotech and Tff Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Oncolytics Biotech and Tff Pharmaceuticals

The main advantage of trading using opposite Oncolytics Biotech and Tff Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncolytics Biotech position performs unexpectedly, Tff Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tff Pharmaceuticals will offset losses from the drop in Tff Pharmaceuticals' long position.
The idea behind Oncolytics Biotech and Tff Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk